Epona EHV-1, EHV-4, Equine influenza Lavage

Epona EHV-1, EHV-4, Equine influenza Lavage

Symptoms

Main clinical signs

Equine respiratory diseases, grouped under the term acute respiratory syndrome, may cause a complex and non-specific set of clinical signs such as pyrexia, serous nasal discharge or inflammation of the upper respiratory tract. Equine herpesvirus 1 (EHV-1) belongs to the family Herpesviridae and causes equine rhinopneumonitis, together with herpesvirus 4. The disease may occur in a respiratory form (nasal discharge, cough), an abortive form (ataxia, locomotor disorders, fever, incontinence) or a neurological form (paresis, incoordination, paralysis) that may lead to death. The virus may also cause a latent infection, during which the horse shows no clinical signs. As this condition is transmissible between horses, isolation and identification of affected animals are essential to limit its spread within an equine facility. Equine herpesvirus 4 (EHV-4) belongs to the family Herpesviridae and causes equine rhinopneumonitis, together with herpesvirus 1. In infected horses showing clinical signs, disease severity is influenced by age, physical condition, type of infection (primary, secondary or related to reactivation of a latent virus), immune status and strain virulence. Spread between horses is rapid and occurs by nasal inhalation or direct contact. The equine influenza virus belongs to the family Orthomyxoviridae and the genus Influenza type A. The disease has a short incubation period (2 to 5 days) and may affect most of the horses in a stable within a matter of hours. The most common clinical signs are high fever, depression, anorexia, serous nasal discharge and a cough (from occasional to paroxysmal) that may be painful. In adult horses, mortality is very low; when it occurs, it is most often due to secondary bacterial infections. Young foals, however, may die from complications of pneumonia. Epona EHV-1 & 4 Influenza Lavage tests are next-generation molecular tests that detect and differentiate the pathogen in a simple, reliable and rapid way, enabling the affected animal to be isolated and treated before the first clinical signs appear. Unlike conventional PCR reactions, the Epona tests are carried out in just a few steps on a portable, easy-to-use reading system. Results can therefore be obtained in under 40 minutes directly in your clinic.

Advantages

Key benefits

• Rapid detection and differentiation of the target pathogens.
• Simple, reliable and rapid workflow for routine veterinary use.
• Supports earlier case management, isolation and treatment decisions.
• Compatible with a portable, easy-to-use reading system.
• Results available in under 40 minutes.
• Suitable for use in the clinic and, where relevant, in the field.

Indications

Recommended use

Tests are intended for in vitro diagnostic use by veterinarians in accordance with the user guides, manuals and technical specifications.